Related Experiment Video
Updated: May 30, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Iron deficiency in Brazilian infants with sickle cell disease
Priscila C Rodrigues1, Rocksane C Norton, Mitiko Murao
1Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG. Médica, Fundação Hemominas, Belo Horizonte, MG. Brazil. <vianamb@gmail.com>
Insights
Most infants with sickle cell disease (SCD) do not have iron deficiency, but some do, especially those with SC hemoglobin. Iron supplementation may be considered but should stop after blood transfusions.
Area of Science:
- Hematology
- Pediatrics
- Nutritional Science
Background:
- Sickle cell disease (SCD) is a genetic blood disorder.
- Iron metabolism in infants with SCD requires careful monitoring.
- Prophylactic iron supplementation guidelines for infants with SCD are not well-established.
Purpose of the Study:
- To evaluate iron deficiency or overload in infants with SCD.
- To inform decisions regarding prophylactic iron supplementation for this population.
Main Methods:
- A cross-sectional and retrospective study of 135 infants under 2 years old with SS or SC hemoglobin.
- Assessed iron status using mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), transferrin saturation (TS), and ferritin.
- 12.6% of infants received blood transfusions before laboratory tests.
Main Results:
- SC hemoglobin infants showed significantly lower ferritin and TS (p < 0.001).
- 17.8% of infants met criteria for iron deficiency, predominantly those with SC hemoglobin (p = 0.003).
- Iron deficiency was present in 19.5% of infants not transfused; elevated ferritin was observed in 11.3%, mostly transfused infants.
Conclusions:
- Most infants with SCD do not develop iron deficiency, but a notable deficit exists in some.
- Infants with SCD, particularly SC hemoglobin type, may benefit from prophylactic iron.
- Iron supplementation should be discontinued following the first blood transfusion in infants with SCD.
Objective:
To assess iron deficiency or overload in infants with sickle cell disease in order to support the decision to recommend (or not) iron prophylactic supplementation in this population.
Methods:
Cross-sectional and retrospective study with 135 infants below 2 years old (66 boys and 69 girls), 77 with SS and 58 with SC hemoglobin, born between 2005 and 2006 in Minas Gerais, Brazil. Indicators of possible iron deficiency were: mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), transferrin saturation (TS), and ferritin. Blood transfusions had been given to 17 infants (12.6%, 95% confidence interval [95%CI] 7.0-18.2%) before laboratory tests were done.
Results:
Ferritin and TS were significantly lower in SC infants (p < 0.001). When two indices were considered for the definition of iron deficiency (low MCV or MCH plus low ferritin or TS), 17.8% of children (95%CI 11.3-24.3%) presented iron deficiency, mainly those with SC hemoglobin (p = 0.003). An analysis of infants who were not given transfusions (n = 118) showed that 19.5% presented iron deficiency. Fifteen infants (11.3%, 95%CI 5.9-16.7%) presented increased ferritin; the majority had been transfused.
Conclusions:
Most infants with sickle cell disease do not develop iron deficiency, though some have a significant deficit. This study indicates that infants with sickle cell disease, mainly those with SC hemoglobin, may receive prophylactic iron; however, supplementation should be withdrawn after the first blood transfusion.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group
The Periodic Table and Organismal Elements
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
